TuHURA Biosciences, Inc./NV — Form 8-K
Filed August 19, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
TuHURA Biosciences filed an 8-K on 2026-08-19 disclosing Item 3.02 (unregistered equity sales) and Item 5.07 (shareholder vote submission). The filing document itself contains no dollar amounts, share counts, pricing, counterparty names, or vote details—only structural metadata and form headers are visible. Specific transaction terms cannot be determined from this filing excerpt.
Why this rating
No quantified facts disclosed (amounts, terms, or vote outcome missing). Without specifics, cannot assess materiality relative to $111M market cap. Routine 8-K form filing.
Extracted items
- 3.02
- 5.07 shareholder vote
- 9.01 exhibits
See more from August 19, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.